FM
FMR LLC disclosed a 10.4% stake in COAG
FMR LLC reported owning 10.4% of Hemab Therapeutics Holdings, Inc. (COAG) (4,871,850 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G